Alterity Therapeutics Limited (ATHE) News Headlines

▮ More

Date

Headline

6/23/2021 9:25:43 AM Alterity Therapeutics Receives European Union Regulatory Guidance For ATH434 Phase 2 Trial

4/21/2021 8:11:00 AM ATH434 protects brain cells and improves motor function in Parkinsonian disorder (Press Release)

2/9/2021 8:56:41 AM Alterity Announces Funding From Michael J. Fox Foundation For ATH434 Dose Optimization

2/9/2021 1:47:03 AM ATHE Gets Funds For Parkinson's Research, No Safety Issues For QURE's Trial, TNXP On Watch

1/14/2021 5:36:44 AM Pre-market Movers In Healthcare Sector: ORGO, NK, APYX, BIOL, ATHE, ACER…

1/7/2021 8:19:50 AM Alterity Therapeutics Appoints David Stamler As CEO

1/5/2018 1:20:37 PM B. Riley FBR Starts Prana Biotechnology Ltd (PRAN) At Buy With $4.00 Price Target

Older Articles